Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BMS reorganization

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb is consolidating its three nonpharmaceutical units into a new healthcare group, which will "help us better identify and capitalize on the strategic opportunities of those businesses," the firm announces Sept. 20. Under the reorganization, the presidents of Mead Johnson Nutritionals, ConvaTec and BMS Medical Imaging will report directly to CEO Peter Dolan on an interim basis. The firm also is consolidating its U.S. and international pharmaceutical operations into one group in order to "realize greater efficiencies," Dolan said. The unit will be headed by Lamberto Andreotti, who has been promoted to executive VP of BMS and president of Worldwide Pharmaceuticals...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098664

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel